StockData
Innoviva, Inc. logo

Innoviva, Inc. (INVA) stock

INVANasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 4, 2026Score 14/3039% below fair value
$18.40+0.10 (+0.55%)

Close on Nov 18, 2026Market cap $1.33BP/E 9.3Yield –

Innoviva market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Innoviva's market cap was $1.37B on Nov 11, 2026, against $1.62B a year earlier. Over the last 5 years it ranged from $778.37M to $1.74B, with a median of $1.14B.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$1.37B-8.3%
2025Dec 31, 2025$1.49B+37.6%
2024Dec 31, 2024$1.09B+5.2%
2023Dec 29, 2023$1.03B+11.7%
2022Dec 30, 2022$924.53M-22.9%
2021Dec 31, 2021$1.20B-4.6%
2020Dec 31, 2020$1.26B-12.4%
2019Dec 31, 2019$1.43B-28.4%
2018Dec 31, 2018$2.00B+8.9%
2017Dec 29, 2017$1.84B+44.9%
2016Dec 30, 2016$1.27B+4.8%
2015Dec 31, 2015$1.21B-22.6%
2014Dec 31, 2014$1.57B-60.3%
2013Dec 31, 2013$3.94B+81.1%
2012Dec 31, 2012$2.18B+36.6%
2011Dec 30, 2011$1.59B+0.8%
2010Dec 31, 2010$1.58B–

More Innoviva figures

See a number that looks wrong?